Ask for high quality link by putting your email below
Ask for high quality link by putting your email below
View and download on Slideshare (low quality) : https://fr.slideshare.net/hcspharma/development-of-a-neuroproctection-assay-for-parkinsons-disease-in-vitro-model-using-hcs
Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.
BIOMIMESYS® has taken place in the panel of the future medicine on the 27th of September. The next step has arrived, and Nathalie Maubon CEO of HCS Pharma has taken BIOMIMESYS® all the way to Read more…
5 Comments
Our feedback of Drug Discovery 2015 in Telford | HCS-pharma · September 14, 2015 at 9:03 am
[…] first one was about the development of a neuroprotection assay as a Parkinson’s desease model in 2D culture. First results on 3D culture, where we can see the neurites connecting different spheroids, were […]
Elrig » Event in BrusselsElrig · December 2, 2015 at 10:52 am
[…] Operetta machine. This machine allows us to take images in a 3D culture as shown in these posters: neuroprotection model for parkinson disease and oncology and performed also really nice images showed in these other posters: hepatotoxicity […]
ELRIGfr » Notre événement de Bruxelles en Octobre 2015ELRIGfr · July 10, 2016 at 4:12 pm
[…] machine. This machine allows us to take images in a 3D culture as shown in these posters: neuroprotection model for parkinson disease and oncology and performed also really nice images showed in these other […]
Our feedback of lab automation congress of ELRIGfr in Bruxelles | HCS-pharma · March 16, 2017 at 10:08 am
[…] Operetta machine. This machine allows us to take images in a 3D culture as shown in these posters: neuroprotection model for parkinson disease and oncology and performed also really nice images showed in these other posters: hepatotoxicity […]
Our feedback of lab automation congress of ELRIGfr in Bruxelles | HCS Pharma · November 30, 2020 at 11:21 am
[…] Operetta machine. This machine allows us to take images in a 3D culture as shown in these posters: neuroprotection model for parkinson disease and oncology and performed also really nice images showed in these other posters: hepatotoxicity […]